![Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet](https://www.thelancet.com/cms/attachment/542d7f15-4e95-4209-9495-179329acbb6e/gr1_lrg.jpg)
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020–21 - The Lancet
![Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet](https://www.thelancet.com/cms/asset/1ca592be-4bb8-4fb1-a5ea-f55f3f7a73a3/gr1.jpg)
Trastuzumab deruxtecan versus trastuzumab emtansine in patients with HER2-positive metastatic breast cancer: updated results from DESTINY-Breast03, a randomised, open-label, phase 3 trial - The Lancet
![Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology](https://www.thelancet.com/cms/attachment/ad9b0376-8e45-470e-a6b1-961f0566c870/gr1.jpg)
Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials - The Lancet Oncology
![Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR](https://www.cdc.gov/mmwr/volumes/69/wr/social-media/mm6915e3_HospitalizationsCOVID19_IMAGE_08April20_1200x675-medium.jpg?_=57715)
Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019 — COVID-NET, 14 States, March 1–30, 2020 | MMWR
![6-month neurological and psychiatric outcomes in 236 379 survivors of COVID- 19: a retrospective cohort study using electronic health records - The Lancet Psychiatry 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID- 19: a retrospective cohort study using electronic health records - The Lancet Psychiatry](https://www.thelancet.com/cms/attachment/683b098c-fd04-4108-84eb-154f8e2d04fc/gr1_lrg.jpg)
6-month neurological and psychiatric outcomes in 236 379 survivors of COVID- 19: a retrospective cohort study using electronic health records - The Lancet Psychiatry
![GEN 3 MCK | MICRO CONVERSION KIT | GLOCK 17/19/19x/20/21/22/23/25/31/32/45/ 47 - CAA Gear Up - CAA USA GEN 3 MCK | MICRO CONVERSION KIT | GLOCK 17/19/19x/20/21/22/23/25/31/32/45/ 47 - CAA Gear Up - CAA USA](https://g3y3u7c6.rocketcdn.me/wp-content/uploads/2021/12/MCK-gen3-product-image.jpeg)
GEN 3 MCK | MICRO CONVERSION KIT | GLOCK 17/19/19x/20/21/22/23/25/31/32/45/ 47 - CAA Gear Up - CAA USA
![Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet](https://www.thelancet.com/cms/attachment/33aa278f-d872-4e73-b20b-cca4e70e6370/gr1d_lrg.jpg)
Pandemic preparedness and COVID-19: an exploratory analysis of infection and fatality rates, and contextual factors associated with preparedness in 177 countries, from Jan 1, 2020, to Sept 30, 2021 - The Lancet
![Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis | Scientific Reports Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis | Scientific Reports](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41598-022-13680-6/MediaObjects/41598_2022_13680_Fig1_HTML.png)